WEHRWEIN SVEN 4

What Happened
Sven Wehrwein, a director of AtriCure, received a grant of 6,144 restricted shares on May 18, 2026. The shares were issued at $0.00 per share (total reported value $0) as an award under the company's equity plan. This is a compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-18; Grant type: Award/Grant (code A).
• Price: $0.00 per share; Shares granted: 6,144; Reported total value: $0.
• Shares owned after the transaction: Not specified in the filing.
• Footnote: The restricted shares were granted under the AtriCure, Inc. 2023 Stock Incentive Plan and will vest on the one-year anniversary of the grant date.
• Filing: Form 4 filed 2026-05-20 — appears to have been filed on a timely basis.

Context
Restricted stock awards are typical for director compensation and vest over time; they are not an immediate cash purchase or sale and do not by themselves indicate a change in the director’s market view. The shares become available to the holder only after vesting (here, one year).